CN111358864A - External medicine for treating rheumatic bone diseases - Google Patents

External medicine for treating rheumatic bone diseases Download PDF

Info

Publication number
CN111358864A
CN111358864A CN202010272230.9A CN202010272230A CN111358864A CN 111358864 A CN111358864 A CN 111358864A CN 202010272230 A CN202010272230 A CN 202010272230A CN 111358864 A CN111358864 A CN 111358864A
Authority
CN
China
Prior art keywords
parts
root
chinese
treating
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010272230.9A
Other languages
Chinese (zh)
Inventor
李燕波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Faduoli Decoration Material Co ltd
Original Assignee
Chongqing Faduoli Decoration Material Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Faduoli Decoration Material Co ltd filed Critical Chongqing Faduoli Decoration Material Co ltd
Priority to CN202010272230.9A priority Critical patent/CN111358864A/en
Publication of CN111358864A publication Critical patent/CN111358864A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/583—Snakes; Lizards, e.g. chameleons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716—Clematis (leather flower)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/758—Zanthoxylum, e.g. pricklyash
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Abstract

The invention discloses an external medicine for treating rheumatoid bone diseases, which comprises the following active ingredients in parts by weight: daphne giraldii nitsche, giant knotweed rhizome, polygala fallax hemsl, rhubarb, hiraute shiny bugleweed herb, angelica dahurica, asarum, tripterygium wilfordii, mint, szechuan lovage rhizome, myrrh, pine pollen, divaricate saposhnikovia root, Chinese starjasmine stem, shinyleaf pricklyash root, eucommia bark, suberect spatholobus stem, golden thread, xanthium sibiricum, Chinese gall, clematis root, corydalis tuber, white snake skin, argyi leaf, slenderstyle acanthopanax bark. The traditional Chinese medicine composition has the effects of promoting blood circulation, dredging collaterals, relieving swelling and pain, removing blood stasis and clearing damp, has super strong penetrability, can accelerate blood circulation by penetrating into deep tissues of skin to generate local heating, can relieve blocked meridians and collaterals, relieve swelling and remove blood stasis, and repair local damaged tissues to achieve the effect of quickly relieving pain, and has the advantages of small dosage, quick response and obvious curative effect; the invention is suitable for rheumatism, hyperosteogeny, cervical spondylosis, cervical and lumbar spinal stenosis and other diseases, and the preparation process is simple and feasible and is suitable for popularization and application.

Description

External medicine for treating rheumatic bone diseases
Technical Field
The invention relates to the technical field of treatment of rheumatic bone diseases, in particular to an external medicine for treating the rheumatic bone diseases.
Background
Rheumatism is mainly caused by poor blood circulation caused by wind cold, and the diseases are caused by poor nutrition supply of muscles, ligaments, bursa and fascia. The rheumatic bone disease is a chronic systemic disease which is lingering and difficult to heal, the disease starts slowly at the beginning, and the symptoms of the patient such as tiredness and hypodynamia, weight loss, poor appetite, low fever, numbness and stabbing pain of hands and feet and the like are caused from the beginning. Later on, symptoms such as joint pain, stiffness, swelling of the surrounding skin, hot flashes, pain caused by automatic and passive movements occur. Many joints of a patient are affected, then arthritis, joint stiffness, distending pain and the like are developed, the patient is easy to have fever, accelerated pulse, anemia and joint deformity along with the aggravation of the disease of the patient with the rheumatic bone disease, and even serious patients influence the normal life, so the life is greatly afflicted.
Currently, the treatment of rheumatoid bone diseases includes western medicine treatment and traditional Chinese medicine treatment. Wherein, the western medicine treatment comprises drug treatment, physical treatment, surgical treatment, rehabilitation treatment, special treatment and the like. However, the western medicine treatment usually has the symptoms and root causes, long treatment time, poor curative effect, high cost and extremely high operation risk, and the western medicine has great harm to the body and is easy to influence the body health after long-term use. The traditional Chinese medicine treatment mostly adopts the methods of relaxing tendons and activating collaterals, promoting blood circulation and removing blood stasis and the like by taking traditional Chinese medicines orally, the treatment effect is not obvious, or the traditional Chinese medicines are taken effectively for the first time and then have no effect, the curative effect is not lasting, the recurrence rate is high, and the traditional Chinese medicines are inconvenient to take orally, some traditional Chinese medicines have irritation to the stomach, and adverse side effects are easy to generate.
Disclosure of Invention
The invention aims to solve the defects in the prior art and provides an external medicine for treating rheumatoid bone diseases;
the invention aims to provide an external medicine for treating rheumatoid bone diseases, which comprises the following active ingredients in parts by weight: 8-20 parts of daphne giraldii nitsche, 10-25 parts of giant knotweed rhizome, 5-15 parts of polygala fallax hemsl, 3-18 parts of rheum officinale, 4-12 parts of herba lycopi, 3-11 parts of angelica dahurica, 6-17 parts of asarum, 5-20 parts of tripterygium wilfordii, 8-15 parts of mint, 3-15 parts of ligusticum wallichii, 4-18 parts of myrrh, 9-15 parts of pollen pini, 8-20 parts of radix sileris, 4-18 parts of Chinese starjasmine stem, 4-15 parts of radix zanthoxyli, 3-12 parts of eucommia bark, 2-10 parts of caulis spatholobi, 5-12 parts of coptis chinensis, 3-10 parts of xanthium sibiricum, 8-15 parts of gallnut, 5-12 parts of radix clematidis, 8-12 parts of corydalis tuber, 2-8 parts of white snake skin, 7-16 parts of folium artemisiae argyi, 2-10 parts of caulis spatholobi, 4-12 parts of radix angelicae pubescentis, 3-15 parts of long-noded pit viper and 2-12 parts of hippocampus.
Preferably, the active ingredients of the traditional Chinese medicine composition are prepared from the following traditional Chinese medicine raw materials in parts by weight: 12 parts of daphne giraldii nitsche, 15 parts of giant knotweed rhizome, 15 parts of polygala fallax hemsl, 4 parts of rhubarb, 6 parts of hiraute shiny bugleweed herb, 5 parts of angelica dahurica, 8 parts of asarum, 12 parts of tripterygium wilfordii, 8 parts of mint, 6 parts of ligusticum wallichii, 12 parts of myrrh, 12 parts of pollen pini, 15 parts of divaricate saposhnikovia root, 6 parts of Chinese starjasmine stem, 7 parts of radix zanthoxyli, 5 parts of eucommia bark, 6 parts of caulis spatholobi, 8 parts of coptis chinensis, 5 parts of xanthium sibiricum, 10 parts of Chinese gall, 12 parts of radix clematidis, 10 parts of corydalis tuber, 7 parts of white snake skin, 12 parts of folium artemisiae argyi, 6.
The invention also aims to provide a preparation method of the external medicine for treating the rheumatoid bone disease, which comprises the following steps:
s1, cleaning: washing the Chinese medicinal raw materials of daphne giraldii nitsche, giant knotweed rhizome, polygala fallax hemsl, rhubarb, hiraute shiny bugleweed herb, dahurian angelica root, asarum, common threewingnut root, mint, szechuan lovage rhizome, myrrh, pine pollen, divaricate saposhnikovia root, Chinese starjasmine stem, shinyleaf pricklyash root, suberect spatholobus stem, golden thread, Chinese gall, eucommia bark, clematis root, corydalis tuber, white snake skin, argy wormwood leaf, slenderstyle acanthopanax bark, safflower, Chinese angelica, suberect spatholobus stem, doubleteeth pube;
s2, crushing: respectively crushing the dried Chinese medicinal raw materials, sieving the crushed Chinese medicinal raw materials with a 50-90-mesh sieve, and mixing to obtain Chinese medicinal mixed powder A;
s3, fermentation: adding the mixed powder A into a fermentation tank filled with cold boiled water, completely immersing the powder A in the cold boiled water, sealing the fermentation tank, and fermenting at room temperature for 15-25 days to obtain fermentation broth;
s4, subpackaging: the obtained fermentation liquor is packaged in sterilized reagent bags.
Preferably, in step S3, the added Chinese medicinal powder A is 8-15 times the weight of the Chinese medicinal powder A, and the fermentation time is 20-25 days.
The invention also aims to provide the application of the external medicine for treating the rheumatoid bone diseases in treating the rheumatoid bone diseases.
Preferably, the external medicine for treating the rheumatoid bone disease is directly applied to an affected part, applied to the affected part and then applied with a moisturizing film, or applied to the affected part after being heated.
Compared with the prior art, the invention has the following beneficial effects:
the invention adopts the fermented aqueous solution prepared by fermenting thirty-two traditional Chinese medicinal materials, not only has the effects of activating blood circulation and removing obstruction in channels, relieving swelling and pain, and removing blood stasis and eliminating dampness, but also has the characteristics of durability, and has super strong permeability, and the fermented aqueous solution can penetrate into deep tissues of skin to generate local heating, dredge blocked channels and collaterals, accelerate blood circulation, relieve swelling and remove blood stasis, repair local damaged tissues and achieve the effect of quickly relieving pain, and has the advantages of small dosage, quick response and obvious curative effect; is suitable for treating rheumatism, rheumatoid disease, hyperosteogeny, arthritis, cervical spondylosis, scapulohumeral periarthritis, cold and cool numbness of waist and legs, sciatica, cervical and lumbar spinal stenosis, tenosynovitis, tennis elbow, traumatic injury, sprain, blood stasis, etc., has the effects of relieving swelling and resolving hard mass for hyperplasia of mammary glands and lobular hyperplasia of gynecology, and is also suitable for treating cold arthralgia, and the symptoms of dispelling dampness, removing cold, relieving swelling, dredging collaterals, relieving pain, etc. The invention has simple and feasible manufacturing process and is suitable for large-scale popularization and application.
According to the records of the traditional Chinese medicine history, the pharmacological activity of the medicinal materials is as follows: daphne giraldii nitsche: has effects in expelling pathogenic wind, removing dampness, promoting blood circulation, and relieving pain; giant knotweed rhizome: has effects in promoting diuresis, eliminating jaundice, clearing away heat and toxic materials, dispelling blood stasis, relieving pain, relieving cough, and eliminating phlegm; radix Polygalae Fallacis: contains senegenin, tenuifolin, 1, 7-dimethoxy 2, 3-methylenedioxy ketone, sinapic acid, ferulic acid, etc., and has effects of invigorating qi and blood, invigorating spleen, promoting diuresis, promoting blood circulation, and regulating menstruation; and (3) long-noded pit viper: the product is the whole body of dried Agkistrodon acutus (Agkistrodon acutus) belonging to the family Agkistrodon, and has effects of dispelling pathogenic wind, dredging collaterals, and relieving spasm, and the Agkistrodon acutus can also effectively reduce skin allergy; rhizoma corydalis: sudden blood rushing upwards can be used for promoting qi circulation, relieving pain, promoting blood circulation, removing blood stasis, and treating traumatic injury due to blood loss; folium artemisiae argyi: regulating menstruation, stopping bleeding, preventing miscarriage, relieving metrorrhagia, dispelling cold, removing dampness, tranquilizing mind, resisting allergy, and treating rheumatic arthritis, and folium Artemisiae Argyi also has antibacterial and antiviral effects; cortex acanthopanacis: dispel wind-damp, tonify liver and kidney, strengthen tendons and bones, activate blood. In clinic, the medicine is used for treating the pain of waist and knees, arthralgia, sinew and muscle contracture, traumatic injury, fracture, edema, beriberi, moist scrotum and weak body of rheumatic arthritis; thunder god vine: has effects of dispelling pathogenic wind and removing dampness, promoting blood circulation for removing obstruction in collaterals, and relieving swelling and pain, and can be used for treating joint osteopathia with obvious effect on arthritis; caulis trachelospermi: has effects in dispelling pathogenic wind, dredging collaterals, cooling blood, relieving swelling, protecting liver and lung, and relieving pain; eucommia ulmoides: the protein contained in the health-care food can hydrolyze 8 amino acids necessary for a human body, has good nourishing property, can tonify liver and kidney, strengthen tendons and bones, regulate thoroughfare and conception vessels, improve soreness and weakness of waist and legs, remove in-vivo garbage, improve the metabolic capability of the human body, prevent muscular and skeletal aging, improve the circulation of the human body, promote urination and clear heat, obviously improve the immunity of a patient and strengthen the body; two-side needle: the traditional Chinese medicine has the effects of promoting blood circulation to remove blood stasis, promoting qi circulation to relieve pain, dispelling wind and dredging collaterals, and detoxifying and reducing swelling, and has an obvious effect on rheumatoid bone diseases; sea horse: has the effects of strengthening body constitution, invigorating kidney, tonifying yang, relaxing muscles and tendons, activating collateral flow, diminishing inflammation, relieving pain, tranquilizing, and relieving anxiety, and has remarkable effect on rheumatic arthropathy; and (3) cocklebur: has effects in dispelling pathogenic wind, removing dampness, inducing resuscitation, and relieving pain; safflower: has effects in promoting blood circulation, removing blood stasis, and relieving pain, and can be used for treating abdominal lump, traumatic injury; frankincense: for wind-damp swelling, descending qi and replenishing essence, treating cholera, relieving pain of various channels, promoting blood circulation, relieving pain and relaxing muscles; clematis root: mainly treats wind, cold pain of waist and knees, treats fracture, promotes old and new retention, and disperses pathogenic wind of skin large intestine; wind prevention: dispelling pathogenic wind, relieving exterior syndrome, eliminating dampness, relieving pain, relieving spasm, and relieving convulsion; radix angelicae pubescentis: it can dispel wind and dampness, dispel cold to alleviate pain, and is clinically used for treating arthralgia due to wind-cold-dampness and pain in waist and knees. Caulis spatholobi: has effects in lowering blood pressure, tonifying blood, promoting hematopoiesis, and resisting cancer; asarum herb: has effects of dispelling pathogenic wind, dispelling cold, promoting diuresis, and inducing resuscitation, and can be used for treating wind-cold headache, nasosinusitis, odontalgia, phlegm and fluid retention cough, and rheumatalgia; myrrh: has antibacterial, antimicrobial, antiinflammatory, astringent, deodorant, flatulence removing, disinfectant, diuretic, channels dredging, phlegm eliminating, antifungal, wound healing, skin benefiting, traumatic injury treating, and bone and muscle pain treating effects. When the tea is drunk, the body is fragrant, the blood circulation is promoted, and the muscles and the tendons are relaxed; radix angelicae: has effects in dispelling pathogenic wind, removing dampness, inducing resuscitation, relieving pain, relieving swelling, and expelling pus; herba lycopi: has effects in promoting blood circulation, regulating menstruation, removing blood stasis, resolving carbuncle, inducing diuresis, and relieving swelling; mint: has effects in dispelling pathogenic wind and heat, removing toxic substance, promoting eruption, clearing away heat and toxic materials, soothing liver, and regulating qi; chinese angelica: has effects in tonifying blood, promoting blood circulation, regulating menstruation, relieving pain, moistening dryness, and smoothing intestine; radix angelicae pubescentis: has effects of dispelling pathogenic wind, removing dampness, dispelling cold and relieving pain; rhubarb: has effects in clearing away heat and toxic materials, purging pathogenic fire, and promoting blood circulation; and (3) cocklebur: has effects in dispelling pathogenic wind and cold, relieving nasal obstruction, dispelling pathogenic wind and dampness, and relieving pain; ligusticum wallichii: has effects in promoting blood circulation, activating qi-flowing, dispelling pathogenic wind, and relieving pain; pollen pini: has effects in moistening heart and lung, invigorating qi, expelling pathogenic wind, and stopping bleeding; caulis trachelospermi: has the effects of dispelling wind, dredging collaterals, cooling blood and relieving swelling, and belongs to the category of wind-damp-dispelling and tendon and bone-strengthening medicines. Gallnut: has astringent, antibacterial, and antidiarrheal effects; clematis root: has effects of dispelling pathogenic wind and dampness, promoting urination, dredging channels, and relieving pain, and can be used for treating wind-cold-dampness-heat, migraine, edema of gallbladder, fishbone sticking throat, and cold pain of legs and legs of waist and knees.
Detailed Description
The technical solution of the present invention will be further explained with reference to the following specific embodiments.
Example 1
An external medicine for treating rheumatism bone disease comprises the following crude drug prescription: 12 parts of daphne giraldii nitsche, 15 parts of giant knotweed rhizome, 15 parts of polygala fallax hemsl, 4 parts of rhubarb, 6 parts of hiraute shiny bugleweed herb, 5 parts of angelica dahurica, 8 parts of asarum, 12 parts of tripterygium wilfordii, 8 parts of mint, 6 parts of ligusticum wallichii, 12 parts of myrrh, 12 parts of pollen pini, 15 parts of divaricate saposhnikovia root, 6 parts of Chinese starjasmine stem, 7 parts of radix zanthoxyli, 5 parts of eucommia bark, 6 parts of caulis spatholobi, 8 parts of coptis chinensis, 5 parts of xanthium sibiricum, 10 parts of Chinese gall, 12 parts of radix clematidis, 10 parts of corydalis tuber, 7 parts of white snake skin, 12 parts of folium artemisiae argyi, 6; the preparation method comprises the following steps:
s1, cleaning: putting the traditional Chinese medicine raw materials in parts by weight into a clean water tank for washing, removing impurities, and then drying;
s2, crushing: respectively crushing the dried Chinese medicinal raw materials, sieving the crushed Chinese medicinal raw materials with a 80-mesh sieve, and mixing to obtain Chinese medicinal mixed powder A;
s3, fermentation: adding the traditional Chinese medicine mixed powder A into a fermentation tank filled with cold boiled water, completely immersing the traditional Chinese medicine mixed powder A in the cold boiled water, sealing the fermentation tank, and fermenting at normal temperature for 25d to obtain fermentation liquor as an external medicine for treating rheumatic bone diseases;
s4, subpackaging: and packaging the obtained fermentation liquor in sterilized reagent bags, and subpackaging by 250mL per bottle.
Example 2
An external medicine for treating rheumatism bone disease comprises the following crude drug prescription: 8 parts of daphne giraldii nitsche, 25 parts of giant knotweed rhizome, 8 parts of polygala fallax hemsl, 16 parts of rhubarb, 12 parts of hiraute shiny bugleweed herb, 10 parts of angelica dahurica, 15 parts of asarum, 5 parts of tripterygium wilfordii, 12 parts of mint, 3 parts of ligusticum wallichii, 8 parts of myrrh, 9 parts of pine pollen, 8 parts of divaricate saposhnikovia root, 12 parts of Chinese starjasmine stem, 15 parts of shinyleaf pricklyash root, 10 parts of eucommia bark, 2 parts of suberect spatholobus stem, 5 parts of coptis root, 8 parts of siberian cocklebur fruit, 8 parts of Chinese gall, 5 parts of clematis root, 12 parts of corydalis tuber, 2 parts of white snake skin, 7 parts of Chinese; the preparation method comprises the following steps:
s1, cleaning: putting the traditional Chinese medicine raw materials in parts by weight into a clean water tank for washing, removing impurities, and then drying;
s2, crushing: respectively crushing the dried Chinese medicinal raw materials, sieving with a 50-mesh sieve, and mixing to obtain Chinese medicinal mixed powder A;
s3, fermentation: adding the traditional Chinese medicine mixed powder A into a fermentation tank filled with cold boiled water, completely immersing the traditional Chinese medicine mixed powder A in the cold boiled water, sealing the fermentation tank, and fermenting at normal temperature for 20 days to obtain fermentation liquor as an external medicine for treating rheumatic bone diseases;
s4, subpackaging: and packaging the obtained fermentation liquor in sterilized reagent bags, and subpackaging by 250mL per bottle.
Example 3
An external medicine for treating rheumatism bone disease comprises the following crude drug prescription: 20 parts of daphne giraldii nitsche, 15 parts of giant knotweed rhizome, 5 parts of polygala fallax hemsl, 13 parts of rhubarb, 4 parts of hiraute shiny bugleweed herb, 3 parts of angelica dahurica, 6 parts of asarum, 20 parts of tripterygium wilfordii, 8 parts of mint, 15 parts of ligusticum wallichii, 18 parts of myrrh, 15 parts of pine pollen, 20 parts of divaricate saposhnikovia root, 12 parts of Chinese starjasmine stem, 4 parts of shinyleaf pricklyash root, 10 parts of eucommia bark, 8 parts of suberect spatholobus stem, 12 parts of coptis root, 10 parts of siberian cocklebur fruit, 15 parts of Chinese gall, 12 parts of clematis root, 8 parts of corydalis tuber, 5 parts of white snake skin, 16 parts of arg; the preparation method comprises the following steps:
s1, cleaning: putting the traditional Chinese medicine raw materials in parts by weight into a clean water tank for washing, removing impurities, and then drying;
s2, crushing: respectively crushing the dried Chinese medicinal raw materials, sieving the crushed Chinese medicinal raw materials by a 90-mesh sieve, and mixing the crushed Chinese medicinal raw materials to obtain Chinese medicinal mixed powder A;
s3, fermentation: adding the traditional Chinese medicine mixed powder A into a fermentation tank filled with cold boiled water, completely immersing the traditional Chinese medicine mixed powder A in the cold boiled water, sealing the fermentation tank, and fermenting at normal temperature for 15 days to obtain fermentation liquor as an external medicine for treating rheumatic bone diseases;
s4, subpackaging: and packaging the obtained fermentation liquor in sterilized reagent bags, and subpackaging by 250mL per bottle.
The application method of the external medicine of the invention is as follows: massaging the affected part for two minutes, and lightly applying for one or two times, wherein the application amount is 0.3-0.5ml according to the pain area, and the effect can be obtained after applying moisture-keeping film or heating for 20-30 min.
The test shows that the medicine taking results of patients with rheumatoid arthritis, cervical spondylosis, cervical and lumbar spinal stenosis and bony spur patients are counted.
TABLE 1 statistics of the pharmacological effects of the topical drugs for the treatment of rheumatic bone diseases prepared in examples 1 to 3
Figure DEST_PATH_IMAGE001
As can be seen from the results of table 1, the external medicine for treating rheumatic bone diseases prepared in embodiments 1 to 3 of the present invention has a good therapeutic effect on patients with rheumatoid arthritis, patients with cervical spondylosis, patients with cervical and lumbar spinal stenosis, and patients with bony spur, and can basically achieve healing. The external medicine for treating the rheumatic bone diseases, which is prepared in the embodiments 1 to 3, has obvious effects of dispelling wind, relieving pain, promoting blood circulation and removing blood stasis, has curative effects on various rheumatic bone diseases, and is small in body injury and toxic and side effects of patients, free of allergy, free of bubbling, safe and suitable for popularization and application.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (6)

1. The external medicine for treating the rheumatoid bone disease is characterized in that the active ingredients of the external medicine are prepared from the following traditional Chinese medicine raw materials in parts by weight: 8-20 parts of daphne giraldii nitsche, 10-25 parts of giant knotweed rhizome, 5-15 parts of polygala fallax hemsl, 3-18 parts of rheum officinale, 4-12 parts of herba lycopi, 3-11 parts of angelica dahurica, 6-17 parts of asarum, 5-20 parts of tripterygium wilfordii, 8-15 parts of mint, 3-15 parts of ligusticum wallichii, 4-18 parts of myrrh, 9-15 parts of pollen pini, 8-20 parts of radix sileris, 4-18 parts of Chinese starjasmine stem, 4-15 parts of radix zanthoxyli, 3-12 parts of eucommia bark, 2-10 parts of caulis spatholobi, 5-12 parts of coptis chinensis, 3-10 parts of xanthium sibiricum, 8-15 parts of gallnut, 5-12 parts of radix clematidis, 8-12 parts of corydalis tuber, 2-8 parts of white snake skin, 7-16 parts of folium artemisiae argyi, 2-10 parts of caulis spatholobi, 4-12 parts of radix angelicae pubescentis, 3-15 parts of long-noded pit viper and 2-12 parts of hippocampus.
2. The external medicine for treating the rheumatoid bone disease as claimed in claim 1, which is characterized in that the active ingredients are prepared from the following traditional Chinese medicine raw materials in parts by weight: 12 parts of daphne giraldii nitsche, 15 parts of giant knotweed rhizome, 15 parts of polygala fallax hemsl, 4 parts of rhubarb, 6 parts of hiraute shiny bugleweed herb, 5 parts of angelica dahurica, 8 parts of asarum, 12 parts of tripterygium wilfordii, 8 parts of mint, 6 parts of ligusticum wallichii, 12 parts of myrrh, 12 parts of pollen pini, 15 parts of divaricate saposhnikovia root, 6 parts of Chinese starjasmine stem, 7 parts of radix zanthoxyli, 5 parts of eucommia bark, 6 parts of suberect spatholobus stem, 8 parts of coptis chinensis, 5 parts of xanthium sibiricum, 5-12 parts of clematis root, 10 parts of corydalis tuber, 7 parts of white snake skin, 12 parts of argy wormwood leaf, 6 parts of cortex acanthopanacis, 2-.
3. A method for preparing the external medicine for treating rheumatoid bone disease according to claim 1 or 2, comprising the steps of:
s1, cleaning: washing the Chinese medicinal raw materials of daphne giraldii nitsche, giant knotweed rhizome, polygala fallax hemsl, rhubarb, hiraute shiny bugleweed herb, dahurian angelica root, asarum, common threewingnut root, mint, szechuan lovage rhizome, myrrh, pine pollen, divaricate saposhnikovia root, Chinese starjasmine stem, shinyleaf pricklyash root, suberect spatholobus stem, golden thread, Chinese gall, eucommia bark, clematis root, corydalis tuber, white snake skin, argy wormwood leaf, slenderstyle acanthopanax bark, safflower, Chinese angelica, suberect spatholobus stem, doubleteeth pube;
s2, crushing: respectively crushing the dried Chinese medicinal raw materials, sieving the crushed Chinese medicinal raw materials with a 50-90-mesh sieve, and mixing to obtain Chinese medicinal mixed powder A;
s3, fermentation: adding the mixed powder A into a fermentation tank filled with cold boiled water, completely immersing the powder A in the cold boiled water, sealing the fermentation tank, and fermenting at room temperature for 15-25 days to obtain fermentation broth as topical medicine for treating rheumatic osteopathia;
s4, subpackaging: the obtained fermentation liquor is packaged in sterilized reagent bags.
4. The external medicine for treating rheumatoid bone disease as recited in claim 1, wherein the added bean curd jelly is 8-15 times the weight of the mixed powder A of the Chinese medicinal materials in step S3, and the fermentation time is 20-25 days.
5. The use of the external preparation for treating rheumatoid bone disease according to claim 1 in the treatment of rheumatoid bone disease.
6. The use of claim 5, wherein the external preparation for treating rheumatoid bone disease is applied to the affected part directly, applied to the affected part and then applied with a moisture-retaining film, or applied to the affected part after heating.
CN202010272230.9A 2020-04-09 2020-04-09 External medicine for treating rheumatic bone diseases Pending CN111358864A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010272230.9A CN111358864A (en) 2020-04-09 2020-04-09 External medicine for treating rheumatic bone diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010272230.9A CN111358864A (en) 2020-04-09 2020-04-09 External medicine for treating rheumatic bone diseases

Publications (1)

Publication Number Publication Date
CN111358864A true CN111358864A (en) 2020-07-03

Family

ID=71199205

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010272230.9A Pending CN111358864A (en) 2020-04-09 2020-04-09 External medicine for treating rheumatic bone diseases

Country Status (1)

Country Link
CN (1) CN111358864A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114010744A (en) * 2021-10-22 2022-02-08 杭州鼎胜生物科技有限公司 Grain medicinal liquor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1470275A (en) * 2003-06-17 2004-01-28 岳凤连 Tianchong-Shuanghua medicinal liquor producing technology
CN101085304A (en) * 2007-06-18 2007-12-12 付先进 Plaster mainly for curing cervical vertebra and lumbar vertebra disease
CN104940868A (en) * 2015-06-10 2015-09-30 李继敏 Traditional Chinese medicine formula for treating cervical spondylosis, and cervical vertebra paste

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1470275A (en) * 2003-06-17 2004-01-28 岳凤连 Tianchong-Shuanghua medicinal liquor producing technology
CN101085304A (en) * 2007-06-18 2007-12-12 付先进 Plaster mainly for curing cervical vertebra and lumbar vertebra disease
CN104940868A (en) * 2015-06-10 2015-09-30 李继敏 Traditional Chinese medicine formula for treating cervical spondylosis, and cervical vertebra paste

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
买买吐松，等: "身痛逐瘀汤内服外敷治疗颈肩腰腿痛104例", 《实用中医内科杂志》 *
吴震西: "关节炎的外治法很多,你认为哪些方法简便有效?", 《中医杂志》 *
张仲源，等: "《中医治疗四肢关节痛》", 31 October 2009 *
曹瑞敏，等: "骨宝搽剂组方的理论研究", 《医学理论与实践》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114010744A (en) * 2021-10-22 2022-02-08 杭州鼎胜生物科技有限公司 Grain medicinal liquor

Similar Documents

Publication Publication Date Title
CN103656238B (en) A kind of Chinese medicine composition for the treatment of rheumatic osteopathia
CN101601796A (en) The herbal fumigation compositions and the priming thereof of treatment arthromyodynia
CN101816760A (en) Chinese medicament for treating rheumatoid disease
CN105031213A (en) Traditional Chine medicine foot bathing powder for treating arthritis and preparation method thereof
CN106620400A (en) Wine drug for treating chronic pain damage
CN102973750A (en) Chinese traditional medicine for curing rheumatic, rheumatoid and gouty arthritis and cervical spondylosis
CN105194159A (en) External medicinal wine for relaxing muscles and stimulating blood circulation
CN103432551B (en) Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia
CN111358864A (en) External medicine for treating rheumatic bone diseases
CN103751465B (en) A kind of medicinal liquor of strengthening tendons and eliminating dampness
CN104491642A (en) Foot bath powder for preventing and treating gout
CN101708292B (en) Chinese medicament for treating rheumatic and rheumatoid diseases
CN104984313B (en) A kind of Traditional Chinese medicinal liquor for treating pernio
CN111265644A (en) Bone-activating pain-relieving plaster and preparation method thereof
CN110038101A (en) A kind of Chinese medicine is dispelled antipruritic external preparation of pain and preparation method thereof
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN108066738B (en) Ointment for treating gouty arthritis and preparation method thereof
CN105998302A (en) Foot bath powder for treating arthritis and preparation method of foot bath powder
CN105362944A (en) Traditional Chinese medicine ointment for treating orthopedics sprain and contusion
CN105381098A (en) Traditional Chinese medicine fumigating and washing agent for treating knee osteoarthritis and nursing method
CN103263543B (en) Care solution for postoperative fumigation treatment on fracture patient
CN105250807A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN104758830A (en) Traditional Chinese medicine composition for treating bone disease and skin injury and preparation method of traditional Chinese medicine composition
CN104587394A (en) Traditional Chinese medicine composition for treating delayed union and nonunion
CN104147131B (en) External traditional Chinese medicine composition for preventing and treating bone joint pain

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200703

WD01 Invention patent application deemed withdrawn after publication